SCHEMBL23837465

SCHEMBL23837465

C=COC(=O)c1c(Cl)ccc2c1OB(O)[C@@H](NC(C)=O)C2

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23129690 0.85 ALOX5 (0.36) —
SCHEMBL17347744 0.85 ALOX5 (0.36) —
SCHEMBL23837292 0.84 POLB (0.32) —
SCHEMBL17347774 0.83 CAT (0.33) —
SCHEMBL23130010 0.83 CAT (0.33) —
SCHEMBL17347814 0.80 POLB (0.30) —
SCHEMBL23129980 0.80 POLB (0.30) —
SCHEMBL17347832 0.76 ALOX5 (0.36) —
SCHEMBL23130166 0.76 ALOX5 (0.36) —
SCHEMBL23130177 0.74 ALOX5 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3882252-A1 BETA-LACTAMASE INHIBITORS Venatorx Pharmaceuticals, Inc. (US) 2021-09-22 — — EP disclosed
Send feedback